Logo image of 1ISRG.MI

INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR

538.4  +4.2 (+0.79%)

Fundamental Rating

6

Overall 1ISRG gets a fundamental rating of 6 out of 10. We evaluated 1ISRG against 55 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. This makes 1ISRG very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year 1ISRG was profitable.
In the past year 1ISRG had a positive cash flow from operations.
In the past 5 years 1ISRG has always been profitable.
Each year in the past 5 years 1ISRG had a positive operating cash flow.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 12.39%, 1ISRG belongs to the top of the industry, outperforming 89.09% of the companies in the same industry.
1ISRG's Return On Equity of 14.05% is amongst the best of the industry. 1ISRG outperforms 85.45% of its industry peers.
1ISRG has a Return On Invested Capital of 10.67%. This is amongst the best in the industry. 1ISRG outperforms 87.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ISRG is in line with the industry average of 8.28%.
The last Return On Invested Capital (10.67%) for 1ISRG is above the 3 year average (10.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.39%
ROE 14.05%
ROIC 10.67%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

1ISRG's Profit Margin of 27.81% is amongst the best of the industry. 1ISRG outperforms 92.73% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a better Operating Margin (28.14%) than 98.18% of its industry peers.
1ISRG's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 67.46%, 1ISRG is in the better half of the industry, outperforming 69.09% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 28.14%
PM (TTM) 27.81%
GM 67.46%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.19
WACC8.96%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 5.22 indicates that 1ISRG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.22, 1ISRG belongs to the top of the industry, outperforming 94.55% of the companies in the same industry.
A Quick Ratio of 4.54 indicates that 1ISRG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.54, 1ISRG belongs to the top of the industry, outperforming 96.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.22
Quick Ratio 4.54
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

7

3. Growth

3.1 Past

1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.37%, which is quite impressive.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
1ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.24%.
1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.37%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%38.12%
Revenue 1Y (TTM)17.24%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%25.16%

3.2 Future

1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.44% yearly.
Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.11% on average per year.
EPS Next Y12.03%
EPS Next 2Y14.8%
EPS Next 3Y15.12%
EPS Next 5Y14.44%
Revenue Next Year17.28%
Revenue Next 2Y16.4%
Revenue Next 3Y15.94%
Revenue Next 5Y14.11%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 79.76, the valuation of 1ISRG can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as 1ISRG.
1ISRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
Based on the Price/Forward Earnings ratio of 71.18, the valuation of 1ISRG can be described as expensive.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than 61.82% of the companies in the same industry.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 79.76
Fwd PE 71.18
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 61.82% of the companies listed in the same industry.
1ISRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 159.9
EV/EBITDA 70.05
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 15.12% in the coming years.
PEG (NY)6.63
PEG (5Y)6.95
EPS Next 2Y14.8%
EPS Next 3Y15.12%

More info and screens

0

5. Dividend

5.1 Amount

1ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTUITIVE SURGICAL INC

BIT:1ISRG (2/28/2025, 7:00:00 PM)

538.4

+4.2 (+0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-23 2025-01-23/amc
Earnings (Next)04-16 2025-04-16/amc
Inst Owners89.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap192.03B
Analysts79.49
Price Target620.61 (15.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.57%
Min EPS beat(2)10.37%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)12.24%
Min EPS beat(4)4.44%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)7.68%
EPS beat(12)10
Avg EPS beat(12)4.92%
EPS beat(16)13
Avg EPS beat(16)7.19%
Revenue beat(2)1
Avg Revenue beat(2)2.49%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)5.12%
Revenue beat(4)1
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.53%
Revenue beat(12)5
Avg Revenue beat(12)0%
Revenue beat(16)7
Avg Revenue beat(16)1.66%
PT rev (1m)1.65%
PT rev (3m)20.36%
EPS NQ rev (1m)-0.15%
EPS NQ rev (3m)-2.11%
EPS NY rev (1m)0.76%
EPS NY rev (3m)2.4%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)0.64%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 79.76
Fwd PE 71.18
P/S 24.96
P/FCF 159.9
P/OCF 86.33
P/B 12.61
P/tB 12.88
EV/EBITDA 70.05
EPS(TTM)6.75
EY1.25%
EPS(NY)7.56
Fwd EY1.4%
FCF(TTM)3.37
FCFY0.63%
OCF(TTM)6.24
OCFY1.16%
SpS21.57
BVpS42.69
TBVpS41.79
PEG (NY)6.63
PEG (5Y)6.95
Profitability
Industry RankSector Rank
ROA 12.39%
ROE 14.05%
ROCE 14.22%
ROIC 10.67%
ROICexc 22.9%
ROICexgc 23.99%
OM 28.14%
PM (TTM) 27.81%
GM 67.46%
FCFM 15.61%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 222.37%
Cap/Sales 13.3%
Interest Coverage 250
Cash Conversion 84.73%
Profit Quality 56.14%
Current Ratio 5.22
Quick Ratio 4.54
Altman-Z N/A
F-Score7
WACC8.96%
ROIC/WACC1.19
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.37%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%38.12%
EPS Next Y12.03%
EPS Next 2Y14.8%
EPS Next 3Y15.12%
EPS Next 5Y14.44%
Revenue 1Y (TTM)17.24%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%25.16%
Revenue Next Year17.28%
Revenue Next 2Y16.4%
Revenue Next 3Y15.94%
Revenue Next 5Y14.11%
EBIT growth 1Y32.03%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year37.81%
EBIT Next 3Y24.38%
EBIT Next 5Y19.91%
FCF growth 1Y73.93%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y33.15%
OCF growth 3Y4.95%
OCF growth 5Y8.61%